Inventor · disambiguated record
Eija Tiainen
Also filed as: TIAINEN EIJA
8 granted patents·8 pending applications·27 citations·filing 1999–2024
80Inventor score
Top patents by PatentIndex Score
16 records- 0191US11098032B2Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitorsORION CORP·Filed 2020·Granted Aug 24, 2021·3 cites·11 claims
- 0287US10717726B2Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitorsORION CORP·Filed 2017·Granted Jul 21, 2020·3 cites·35 claims
- 0381US2024308989A1Pyran derivatives as cyp11a1 (cytochrome p450 monooxygenase 11a1) inhibitorsORION CORP·Filed 2024·Application pending·0 cites
- 0470US12030871B2Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitorsORION CORP·Filed 2021·Granted Jul 9, 2024·0 cites·24 claims
- 0569US2022047540A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2021·Application pending·0 cites
- 0665US2020352898A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2020·Application pending·0 cites
- 0759US6265421B1Phospholamban inhibitors and a method for increasing coronary flowORION CORP·Filed 1999·Granted Jul 24, 2001·21 cites·33 claims
- 0859US2020009103A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2019·Application pending·0 cites
- 0958US2019029990A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2018·Application pending·0 cites
- 1055US9458128B2Catechol O-methyltransferase activity inhibiting compoundsORION CORP·Filed 2013·Granted Oct 4, 2016·0 cites·52 claims
- 1154US2024158377A1Novel salt forms of a 4h-pyran-4-one structured cyp11a1 inhibitorORION CORP·Filed 2022·Application pending·0 cites
- 1254US2024158378A1Solid forms of a 4h-pyran-4-one structured cyp11a1 inhibitorORION CORP·Filed 2022·Application pending·0 cites
- 1353US2017165219A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2016·Application pending·0 cites
- 1440US9890139B2CYP17 inhibitors/antiandrogensORION CORP·Filed 2014·Granted Feb 13, 2018·0 cites·22 claims
- 1537US7425568B2Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmiasORION CORP·Filed 2002·Granted Sep 16, 2008·0 cites·9 claims
- 1635US8318785B2Pharmaceutical compoundsAHLMARK MARKO·Filed 2006·Granted Nov 27, 2012·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →